首页> Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy> Therapeutic strategies to overcome taxane resistance in cancer.

Therapeutic strategies to overcome taxane resistance in cancer.

导出 LinkOut

翻译打印收藏纠错

第一作者： Tuyelee,Das

第一单位： Department of Life Sciences, Presidency University, 86/1 College Street, Kolkata, 700073, West Bengal, India.

作者： Tuyelee,Das ^[1] ; Uttpal,Anand ^[2] ; Swaroop Kumar,Pandey ^[2] ; Charles R,Ashby ^[3] ; Yehuda G,Assaraf ^[4] ; Zhe-Sheng,Chen ^[5] ; Abhijit,Dey ^[6]

作者单位： Department of Life Sciences, Presidency University, 86/1 College Street, Kolkata, 700073, West Bengal, India. ^[1] Department of Life Sciences and the National Institute for Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer-Sheva, 84105, Israel. ^[2] Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, NY, 11439, USA. ^[3] The Fred Wyszkowski Cancer Research Laboratory, Department of Biology, Technion-Israel Institute of Technology, Haifa, 3200003, Israel. ^[4] Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, NY, 11439, USA. Electronic address: chenz@stjohns.edu. ^[5] Department of Life Sciences, Presidency University, 86/1 College Street, Kolkata, 700073, West Bengal, India. Electronic address: abhijit.dbs@presiuniv.ac.in. ^[6]

关键词 Anticancer drugs Apoptotic proteins Cancer Docetaxel Microtubule disruptors Multidrug resistance (MDR)Nano-delivery systems Natural products Paclitaxel (PTX)Taxanes Tumor-suppressor proteins